A: Large, long-term clinical trials are currently underway to investigate the potential brain health benefits of GLP-1 drugs
However, limitations involve unknown user demographics, reliance on self-reported data, and the inability to confirm medication duration or dosage
When a drug goes generic, other companies can manufacture and sell the same active ingredient after patent protection ends, subject to regulatory approvals
There are several ways people can manage the side effects of Semaglutide and Mounjaro
A 2026 preclinical study : A preprint published on bioRxiv in April 2026 by Keskin, Altin, and colleagues examined whether retatrutide influences learning- and memory-related behaviors under conditions of metabolic stress in animal models
doi: 10.1210/endo.143.4.8722 39 SorensonRLBreljeTC